BrightGene Bio Medical Technology C (688166): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 35,23 Renminbi Yuan | 102,74 Renminbi Yuan | 28,74 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 44,21 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 435.794.991 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.223.640,13 | 1.282.551,615 | 1.179.517,532 | 1.017.331,488 | 1.052.408,591 | 785.382,729 | 503.156,657 | 407.503,283 | 316.770,479 | 200.924,791 |
Herstellungskosten | 601.611,553 | 544.950,816 | 521.413,988 | 376.298,728 | 460.671,486 | 353.993,835 | 180.910,883 | 169.301,57 | 130.103,647 | 85.042,347 |
Bruttoergebnis | 622.028,577 | 737.600,799 | 658.103,545 | 641.032,76 | 591.737,105 | 431.388,894 | 322.245,774 | 238.201,712 | 186.666,832 | 115.882,444 |
▸ Brutto-Marge | 50,83% | 57,51% | 55,79% | 63,01% | 56,23% | 54,93% | 64,04% | 58,45% | 58,93% | 57,67% |
Betriebliche Aufwendungen | 511.830,473 | 486.773,378 | 404.500,405 | 376.374,198 | 317.336,979 | 223.124,709 | 196.582,83 | 151.411,95 | 130.120,393 | 97.202,827 |
Operativer Gewinn/Verlust | 110.198,103 | 250.827,421 | 253.603,14 | 264.658,562 | 274.400,126 | 208.264,185 | 125.662,944 | 86.789,763 | 56.546,439 | 18.679,617 |
▸ Operative Marge | 9,01% | 19,56% | 21,5% | 26,01% | 26,07% | 26,52% | 24,97% | 21,3% | 17,85% | 9,3% |
Zinsen (Netto) | -57.409,774 | -41.471,5 | -26.432,975 | -21.471,591 | -9.457,056 | 7.417,157 | 1.343,128 | -282,853 | -5.067,796 | -1.624,05 |
▸ Zinsausgaben | 62.957,015 | 52.435,027 | 44.424,247 | 23.710,368 | 10.366,783 | 2.042,826 | 225,045 | 482,918 | 5.363,692 | 1.731,554 |
▸ Zinseinnahmen | 5.547,242 | 10.963,527 | 17.991,272 | 2.238,777 | 909,727 | 9.459,984 | 1.568,173 | 200,065 | 295,896 | 107,504 |
Andere Ausgaben | 38.879,499 | 52.155,312 | 38.400,105 | 979,75 | 7.488,004 | 24.360,814 | 7.062,162 | 7.285,744 | 2.730,531 | -2.326,567 |
Gewinn vor Steuern | 13.908,831 | 157.200,608 | 188.770,06 | 242.207,221 | 257.455,066 | 191.320,529 | 119.943,91 | 79.221,166 | 48.748,113 | 19.382,133 |
Steueraufwand | - | - | - | 30.780,264 | 19.897,249 | 21.958,619 | 8.860,587 | 6.019,124 | 2.871,681 | 2.321,161 |
Minderheitenanteil | -40.605,85 | -31.966,329 | -13.695,965 | -28.196,215 | -6.393,234 | -520,522 | -0,004 | -0,007 | -0,005 | -0,002 |
Nettogewinn/-verlust | 54.514,681 | 189.166,937 | 202.466,025 | 239.623,173 | 243.951,051 | 169.882,432 | 111.083,327 | 73.202,049 | 45.876,437 | 17.060,974 |
▸ Netto-Marge | 4,46% | 14,75% | 17,17% | 23,55% | 23,18% | 21,63% | 22,08% | 17,96% | 14,48% | 8,49% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.